Company Overview

Update
Founded:
2007
Founders:
Cam Gallagher
Headquarters:
Bethesda, MD
Funding:
$3.20M
Categories:
Biotechnology

DioGenix develops and commercializes non-invasive diagnostic and prognostic treatment response monitoring tests.

Description

Update

DioGenix, Inc. engages in the discovery, development, and commercialization of non-invasive diagnostic, prognostic, and treatment response monitoring tests. Its lead program is designed to provide neurologists with a set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types, and predict response to treatment using non-invasive blood tests. The company was incorporated in 2007 and is based in Gaithersburg, Maryland. As of September 19, 2008, DioGenix, Inc. operates as a subsidiary of Nerveda, Inc.

Current Team (6)

Update

Board Members and Advisors (3)

Update

Funding Rounds (1) - $3.20M

Update

Offices/Locations (2)

Update
  • DioGenix Laboratory

    15010 Broschart Road,

    Suite 200,

    Rockville, MD 20850

    USA

  • HQ

    3 Bethesda Metro Center,

    Suite 700,

    Bethesda, MD 20814

    USA